DB05091InvestigationalSmall molecule
M0002 is an orally-active selective vasopressin antagonist that inhibits water re-absorption from the kidneys. It is a vasopressin 2 antagonist and represents a new class of compounds – aquaretics –... It will be of major benefit to those patients not responding satisfactorily to diuretics alone.
- Primary indication
- Vasopressin regulates renal water resorption through the V2 receptor.Curator reviewed
Resolves to
Targets
What you can answer from here — as of April 02, 2025
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with M0002, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account